Targeting ferroptosis and mitochondrial abnormalities: a promising therapeutic strategy for diabetes and its...

This study aims to explore the interplay between ferroptosis and mitochondrial abnormalities in diabetes and its complications, and to summarize potential therapeutic strategies targeting this interaction.

A systematic literature search was conducted using PubMed and Web of Science up to July 20, 2025, with keywords such as diabetes, mitochondrial abnormalities, lipid peroxidation, and ferroptosis. The integrated evidence regarding the role of ferroptosis and mitochondrial abnormalities (including dynamics imbalance, autophagy disorder, energy metabolism disorder, etc.) in diabetes and its complications was comprehensively evaluated.

Mitochondrial abnormalities (such as fission/fusion imbalance, autophagy defects, and metabolic disorders) significantly exacerbate ferroptosis by promoting reactive oxygen species burst, lipid peroxidation, and iron metabolism disorder. Conversely, ferroptosis exacebates mitochondrial damage, creating a self-sustaining vicious cycle that jointly accelerates the progression of diabetes and its complications. Importantly, interventions targeting regulation of mitochondrial function (such as enhancing mitochondrial autophagy) can effectively inhibit ferroptosis, thereby alleviating diabetes phenotypes.

This study provides a conceptual framework for understanding the mitochondrial-ferroptosis axis in diabetes, highlighting its potential as a therapeutic target.